Barclays’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-192,000
Closed -$49M 7461
2015
Q1
$49M Buy
192,000
+148,400
+340% +$28.6M 0.06% 331
2014
Q4
$5.32M Buy
43,600
+3,100
+8% +$396K 0.01% 1656
2014
Q3
$4.74M Buy
40,500
+16,600
+69% +$1.89M ﹤0.01% 1833
2014
Q2
$2.13M Sell
23,900
-49,800
-68% -$4.67M ﹤0.01% 2535
2014
Q1
$7.37M Sell
73,700
-238,000
-76% -$30.9M 0.01% 1391
2013
Q4
$32.7M Buy
311,700
+101,600
+48% +$12.3M 0.03% 511
2013
Q3
$29M Buy
210,100
+147,800
+237% +$16.4M 0.03% 495
2013
Q2
$4.95M Buy
+62,300
New +$5.09M 0.01% 1641

Other funds holding PCYC

Barclays's PCYC Position: Q2 2015 in Review

Barclays sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 189,579 shares — an estimated $48.3M sold.

Barclays first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $48.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Barclays reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Barclays sold 189,579 PHARMACYCLICS INC shares in Q2 2015, an estimated $48.3M.
  • Barclays first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Barclays's PHARMACYCLICS INC position peaked at $48.3M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.